US regulators have placed on hold a clinical trial testing a combination of Advaxis’ axalimogene filolisbac and AstraZeneca's Imfinzi after a patient died from respiratory failure.
Original Article: Cancer drug study placed on hold after patient death
NEXT ARTICLE